Basic Information
Basic information for LINC00662-223-18aa
Peptide Name LINC00662-223-18aa
Genome Position chr19:27732827-27732880[-]
Species Human
Peptide Sequence MDISKHIEAYNEKSNIPQ
Peptide Length 18
Unique No (LINC00662-201-18aa,LINC00662-205-18aa,LINC00662-207-18aa,LINC00662-212-18aa,LINC00662-213-18aa,LINC00662-214-18aa,LINC00662-215-18aa,LINC00662-216-18aa,LINC00662-217-18aa,LINC00662-219-18aa,LINC00662-220-18aa,LINC00662-221-18aa,LINC00662-222-18aa,LINC00662-224-18aa,LINC00662-225-18aa,LINC00662-227-18aa,LINC00662-230-18aa,LINC00662-231-18aa,LINC00662-232-18aa,LINC00662-233-18aa-1,LINC00662-235-18aa,LINC00662-239-18aa,LINC00662-240-18aa,LINC00662-241-18aa,LINC00662-242-18aa,LINC00662-244-18aa,LINC00662-245-18aa,LINC00662-247-18aa,LINC00662-249-18aa-2,LINC00662-251-18aa,LINC00662-252-18aa,LINC00662-253-18aa,LINC00662-254-18aa,LINC00662-256-18aa,LINC00662-257-18aa,LINC00662-258-18aa,LINC00662-259-18aa,LINC00662-260-18aa,LINC00662-261-18aa,LINC00662-262-18aa,LINC00662-264-18aa,LINC00662-265-18aa,LINC00662-267-18aa,LINC00662-268-18aa,LINC00662-269-18aa,LINC00662-270-18aa,LINC00662-271-18aa,LINC00662-272-18aa,LINC00662-273-18aa,LINC00662-274-18aa,LINC00662-275-18aa,LINC00662-277-18aa)
Grand Average of Hydropathicity -1.0722
Relative Molecular Mass 2423.6
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000656086;LINC00662-223
Transcript Length 1944
Coding Ability 0.2922
DNA Sequence Corresponding to Peptide ATGGACATTTCTAAGCACATTGAGGCCTATAATGAAAAATCAAATATCCCACAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :